Inhibitors of Organic Anion‐Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective-Reference-Cited by-同舟云学术

Inhibitors of Organic Anion‐Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective

Published:2020-03-20 Issue:8 Volume:60 Page:1087-1098
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

McFeely Savannah J.¹,Ritchie Tasha K.¹,Yu Jingjing¹,Nordmark Anna²,Berglund Eva Gil³,Levy Rene H.¹,Ragueneau‐Majlessi Isabelle¹

Affiliation:

1. University of Washington Drug Interaction Solutions Seattle Washington USA

2. Scandinavian Development Services Danderyd Sweden

3. Certara Strategic ConsultingIntegrated Drug Development Oss The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1604

Reference82 articles.

1. US Food and Drug Administration.Clinical Drug Interaction Studies – Study Design Data Analysis and Clinical Implications: Guidance for Industry. [Draft Guidance]2017.

2. European Medicines Agency.Guideline on the Investigation of Drug Interactions.2013.

3. Ministry of Labor Health and Welfare.Drug interaction guideline for drug development and labeling recommendations.Japan;2014.

4. US Food and Drug Administration.FDA guidance for industry on Drug Interaction Studies.2012.

5. US Food and Drug Administration.In Vitro Metabolism‐ and Transporter‐Mediated Drug‐Drug Interaction Studies: Guidance for Industry. [Draft Guidance].2017.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model;Molecular Pharmaceutics;2024-03-26

2. General Framework to Quantitatively Predict Pharmacokinetic Induction Drug–Drug Interactions Using In Vitro Data;Clinical Pharmacokinetics;2023-03-29

3. Uptake Transporters;Reference Module in Biomedical Sciences;2023

4. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake;Molecular Pharmacology;2022-04-05

5. ORGANIC ANION TRANSPORTING POLYPEPTIDES OATP;Drug Transporters;2022-04-05